Journal article
Pharmacological interventions for promoting smoking cessation during pregnancy
R Claire, C Chamberlain, MA Davey, SE Cooper, I Berlin, J Leonardi-Bee, T Coleman
Cochrane Database of Systematic Reviews | WILEY | Published : 2020
Abstract
Background: Tobacco smoking in pregnancy causes serious health problems for the developing fetus and mother. When used by non-pregnant smokers, pharmacotherapies (nicotine replacement therapy (NRT), bupropion, and varenicline) are effective for increasing smoking cessation, however their efficacy and safety in pregnancy remains unknown. Electronic cigarettes (ECs) are becoming widely used, but their efficacy and safety when used for smoking cessation in pregnancy are also unknown. Objectives: To determine the efficacy and safety of smoking cessation pharmacotherapies and ECs used during pregnancy for smoking cessation in later pregnancy and after childbirth, and to determine adherence to smo..
View full abstractGrants
Awarded by National Institutes of Health
Funding Acknowledgements
Internal sources La Trobe University 1996 to date, Australia. UK Centre for Tobacco Control Studies: a Public Health Centre of Research Excellence, UK. NIHR National School For Primary Care Research, UK. Monash University, Australia. 2016 to present External sources Victorian Health Promotion Foundation, Australia. Department of Health, UK funding for EPI-Centre, London University, UK. Public Health Branch Victorian Department of Human Services, Australia. (TC, SC and JLB) National Institute for Health Research (NIHR), Programme Grant for Applied Research programme (grant number RPPG-0615-20003), UK. Australian National Health and Medical Research Centre, Australia. (Fellowship 1161065)